OMIDRIA® Added to Veterans Health Administration National Formulary

Omeros Corporation ( OMER) today announced that the Veterans Administration (VA) has added OMIDRIA ®(phenylephrine and ketorolac intraocular solution 1% / 0.3%) to the VA National Formulary. The VA National Formulary is a listing of drugs and supplies that must be available at all VA facilities for the benefit of U.

S. military veterans. Omeros’ commercial drug OMIDRIA is the first and only FDA-approved product to maintain pupil size by preventing intraoperative miosis and to reduce postoperative pain associated with cataract or lens replacement surgery. It is estimated that approximately 65,000 to 80,000 cataract surgery procedures will be performed in the VA system in 2018. Over 90 percent of all U.S. medical schools are affiliated with a VA facility. The VA conducts the largest education and training effort for health professionals in the nation with nearly all U.S.-trained physicians receiving some or all of their training in the VA system.